Navigation path

Pharmaceuticals - Community Register


Community register of orphan medicinal products


Product information

N-hydroxy-4-(3-methyl-2-(S)-phenyl-butyrylamino) benzamide

EU orphan designation number: EU/3/12/993   
Active ingredient: N-hydroxy-4-(3-methyl-2-(S)-phenyl-butyrylamino) benzamide
Indication: Treatment of neurofibromatosis type 2
Sponsor: Sirius Regulatory Consulting Limited
29 Hamblin Meadow, Eddington, Hungerford, Berkshire, RG17 0HJ, United Kingdom

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
30/04/2012 Orphan designation EMA/OD/164/11 (2012)2989 of 26/04/2012
07/03/2017 Corrigendum (2012)2989 of 26/04/2012